Raymond James analyst Tiago Fauth reiterated a Strong Buy rating and $66.00 price target on Rapport Therapeutics (NASDAQ: RAPP).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE